Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
Inloggen

Welkom bij Scalda & Bohn Stafleu van Loghum

Scalda heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen.Je kunt de producten hieronder links aanschaffen en rechts inloggen.

» Andere revante producten voor Scalda studenten en medewerkers.

Registreer

Schaf de BSL Academy aan: 

BSL Academy mbo AG

Eenmaal aangeschaft kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL.

Heb je een vraag, neem dan contact op met Jan van der Velden.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Inloggen
Top
Quality of Life Research
Gepubliceerd in:

01-05-2014 | Brief Communication

Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse

Auteurs: Alberto Raggi, Ambra Mara Giovannetti, Silvia Schiavolin, Matilde Leonardi, Gennaro Bussone, Licia Grazzi, Susanna Usai, Marcella Curone, Paola Di Fiore, Domenico D’Amico

Gepubliceerd in: Quality of Life Research | Uitgave 4/2014

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

The purpose of the study is to assess validity, reliability and factor structure of the Italian version of Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in patients suffering from chronic migraine (CM) with a history of medication overuse (MO).

Methods

Patients were enroled at hospital admission for withdrawal from MO. Factor analysis was used to confirm the latent structure of the MSQ. Reliability was measured with Cronbach’s alpha coefficient, item-total correlation and inter-item correlation. Construct validity was assessed with Pearson’s coefficient and known-group analysis.

Results

The three-factor structure is basically confirmed. Cronbach’s alpha varied between 0.85 and 0.92; item-total correlations were on average higher than 0.70; average inter-item correlation ranged between 0.63 and 0.65. Correlations were all significant; known-group analysis shows that MSQ score was lower consistently with disease severity.

Conclusions

Our findings confirm the factor structure, reliability and validity of the MSQ and expand results of previous validation studies to the Italian language and to a group of patients with severe CM requiring withdrawal treatment for MO.
vorige artikel The psychosocial impact of dental aesthetics questionnaire—translation and cross-cultural validation in Croatia
volgende artikel Validation of a Quality of Life Questionnaire for Bronchiectasis: psychometric analyses of the Spanish QOL-B-V3.0
Literatuur
1.
Stovner, L. J., Zwart, J. A., Hagen, K., Terwindt, G. M., & Pascual, J. (2006). Epidemiology of headache in Europe. European Journal of Neurology, 13(4), 333–345.PubMedCrossRef
2.
Linde, M., Gustavsson, A., Stovner, L. J., Steiner, T. J., Barré, J., Katsarava, Z., et al. (2012). The cost of headache disorders in Europe: The Eurolight project. European Journal of Neurology, 19(5), 703–711.PubMedCrossRef
3.
Bigal, M. E., & Lipton, R. B. (2011). Migraine chronification. Current Neurology and Neuroscience Reports, 11(2), 139–148.PubMedCrossRef
4.
Bigal, M. E., Serrano, D., Buse, D., Scher, A., Stewart, W. F., & Lipton, R. B. (2008). Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache, 48(8), 1157–1168.PubMedCrossRef
5.
Castillo, J., Munoz, P., Guitera, V., & Pascual, J. (1999). Kaplan Award 1998. Epidemiology of chronic daily headache in the general population. Headache, 39(3), 190–196.
6.
Natoli, J. L., Manack, A., Dean, B., Butler, Q., Turkel, C. C., Stovner, L., et al. (2010). Global prevalence of chronic migraine: A systematic review. Cephalalgia, 30(5), 599–609.PubMed
7.
Lipton, R. B. (2009). Tracing transformation: Chronic migraine classification, progression, and epidemiology. Neurology, 72(Suppl 5), S3–S7.PubMedCrossRef
8.
Raggi, A., Giovannetti, A. M., Leonardi, M., Schiavolin, S., D’Amico, D., Curone, M., et al. (2012). Disability and mood state in patients with episodic and chronic migraine associated to medication overuse. Neurological Sciences, 33(Suppl 1), S169–S171.PubMedCrossRef
9.
D’Amico, D., Grazzi, L., Usai, S., Raggi, A., Leonardi, M., & Bussone, G. (2011). Disability in chronic daily headache: State of the art and future directions. Neurological Sciences, 32(Suppl 1), 71–76.CrossRef
10.
Bigal, M. E., Rapoport, A. M., Lipton, R. B., Tepper, S. J., & Sheftell, F. D. (2003). Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: A comparison of chronic migraine with episodic migraine. Headache, 43(4), 336–342.PubMedCrossRef
11.
Sanders, C., Egger, M., Donovan, J., Tallon, D., & Frankel, S. (1998). Reporting on quality of life in randomised controlled trials: Bibliographic study. British Medical Journal, 317(7167), 1191–1194.PubMedCentralPubMedCrossRef
12.
Fitzpatrick, R., Davey, C., Buxton, M.J. & Jones, D.R. (1998). Evaluating patient-based outcome measures for use in clinical trials. Health Technology Assessment, 2(14), i–iv, 1–74.
13.
Tfelt-Hansen, P., Block, G., Dahlof, C., Diener, H. C., Ferrari, M. D., Goadsby, P. J., et al. (2000). Guidelines for controlled trials of drugs in migraine: Second edition. Cephalalgia, 20(9), 765–786.PubMedCrossRef
14.
Silberstein, S., Tfelt-Hansen, P., Dodick, D. W., Limmroth, V., Lipton, R. B., Pascual, J., et al. (2008). Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults. Cephalalgia, 28(5), 484–495.PubMedCrossRef
15.
Martin, B. C., Pathak, D. S., Sharfman, M. I., Adelman, J. U., Taylor, F., Kwong, W. J., et al. (2000). Validity and reliability of the Migraine-Specific Quality of Life Questionnaire (MSQ Version 2.1). Headache, 40(3), 204–215.PubMedCrossRef
16.
Lipton, R. B., Varon, S. F., Grosberg, B., McAllister, P. J., Freitag, F., Aurora, S. K., et al. (2011). OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine. Neurology, 77(15), 1465–1472.PubMedCrossRef
17.
Cole, J. C., Lin, P., & Rupnow, M. F. (2009). Minimal important differences in the Migraine-Specific Quality of Life Questionnaire (MSQ) version. Cephalalgia, 29(11), 1180–1187.PubMedCrossRef
18.
Bagley, C. L., Rendas-Baum, R., Maglinte, G. A., Yang, M., Varon, S. F., Lee, J., et al. (2012). Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine. Headache, 52(3), 409–421.PubMedCrossRef
19.
Rendas-Baum, R., Bloudek, L. M., Maglinte, G. A., & Varon, S. F. (2013). The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients. Quality of Life Research, 22(5), 1123–1133.PubMedCentralPubMedCrossRef
20.
Silberstein, S. D., Lipton, R. B., & Sliwinski, M. (1996). Classification of daily and near-daily headaches: Field trial of revised IHS criteria. Neurology, 47(4), 871–875.PubMedCrossRef
21.
Ustun, T. B., Chatterji, S., Kostanjsek, N., Rehm, J., Kennedy, C., Epping-Jordan, J., et al. (2010). Developing the World Health Organization Disability Assessment Schedule 2.0. Bulletin of the World Health Organization, 88(11), 815–823.PubMedCentralPubMedCrossRef
22.
Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for the Beck Depression Inventory-II. San Antonio: Psychological Corporation.
23.
D’Amico, D., Mosconi, P., Genco, S., Usai, S., Prudenzano, A. M., Grazzi, L., et al. (2001). The Migraine Disability Assessment (MIDAS) questionnaire: Translation and reliability of the Italian version. Cephalalgia, 21(10), 947–952.PubMedCrossRef
24.
Headache Classification Subcommittee of the International Headache Society. (2004). The international classification of headache disorders: 2nd edition. Cephalalgia, 24(Suppl 1), 9–160.
25.
Cevoli, S., D’Amico, D., Martelletti, P., Valguarnera, F., Del Bene, E., De Simone, R., et al. (2009). Underdiagnosis and undertreatment of migraine in Italy: A survey of patients attending for the first time 10 headache centres. Cephalalgia, 29(12), 1285–1293.PubMedCrossRef
Metagegevens
Titel
Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse
Auteurs
Alberto Raggi
Ambra Mara Giovannetti
Silvia Schiavolin
Matilde Leonardi
Gennaro Bussone
Licia Grazzi
Susanna Usai
Marcella Curone
Paola Di Fiore
Domenico D’Amico
Publicatiedatum
01-05-2014
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 4/2014
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-013-0556-9

Andere artikelen Uitgave 4/2014

The psychosocial impact of dental aesthetics questionnaire—translation and cross-cultural validation in Croatia

  • Brief Communication

A cross-sectional study of psychological complaints and quality of life in severely injured patients

Comparison of face-to-face interview and telephone interview administration of COPD assessment test: a randomized study

How do life-course trajectories of socioeconomic position affect quality of life in patients with diabetes mellitus?

Measurement properties of the Adolescent Quality of Life Mental Health Scale (AQOL-MHS)

Development and evaluation of the PI-G: a three-scale measure based on the German translation of the PROMIS® pain interference item bank